Generalizable AI predicts immunotherapy outcomes across cancers and treatments

Nature Medicine, Published online: 03 July 2026; doi:10.1038/s41591-026-04502-7

COMPASS is a pan-cancer foundation model that predicts immunotherapy response, across cancer types and treatments, from bulk tumor transcriptomes.